<?xml version="1.0" encoding="UTF-8"?>
<ref id="pone.0190877.ref016">
 <label>16</label>
 <mixed-citation publication-type="journal">
  <name>
   <surname>Hurt</surname>
   <given-names>AC</given-names>
  </name>, 
  <name>
   <surname>Besselaar</surname>
   <given-names>TG</given-names>
  </name>, 
  <name>
   <surname>Daniels</surname>
   <given-names>RS</given-names>
  </name>, 
  <name>
   <surname>Ermetal</surname>
   <given-names>B</given-names>
  </name>, 
  <name>
   <surname>Fry</surname>
   <given-names>A</given-names>
  </name>, 
  <name>
   <surname>Gubareva</surname>
   <given-names>L</given-names>
  </name>, 
  <etal>et al</etal>
  <article-title>Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2014–2015</article-title>. 
  <source>Antiviral Res</source>. 
  <year>2016</year>; 
  <volume>132</volume>:
  <fpage>178</fpage>–
  <lpage>185</lpage>. 
  <comment>doi: 
   <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.antiviral.2016.06.001" xmlns:xlink="http://www.w3.org/1999/xlink">10.1016/j.antiviral.2016.06.001</ext-link>
  </comment>
  <?supplied-pmid 27265623?>
  <pub-id pub-id-type="pmid">27265623</pub-id>
 </mixed-citation>
</ref>
